NewAmsterdam Pharma Co N.V.
- Stock
- Ticker NAMS
- ISIN NL00150012L7
- Nasdaq
- US listing in dollars
Performance, volatility and drawdowns of NewAmsterdam Pharma Co N.V. since 11/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $18,863. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −66.2% in 10/2023, measured from the peak in 01/2023. It took 12 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 13 | 3.0 | 19 | 0.3 | 0.0 | 3.0 | 3.7 | 19 |
| Operating income | -43 | -69 | -36 | -55 | -66 | -58 | -65 | -44 |
| EBITDA | -43 | -69 | -36 | -55 | -66 | -58 | -65 | -44 |
| Net income | -92 | -40 | -17 | -72 | -75 | -48 | -64 | -17 |
| Earnings per share | -0.95 | -0.34 | -0.15 | -0.61 | -0.63 | -0.40 | -0.52 | -0.14 |
| Balance sheet | ||||||||
| Total assets | 865 | 818 | 815 | 786 | 769 | 733 | 704 | 688 |
| Liabilities | 107 | 41 | 37 | 58 | 86 | 67 | 73 | 57 |
| Equity | 758 | 777 | 778 | 728 | 683 | 665 | 631 | 631 |
| Cash | 772 | 748 | 564 | 538 | 490 | 458 | 424 | 423 |
| Cash flow | ||||||||
| Operating cash flow | -37 | -36 | -38 | -33 | -41 | -31 | -39 | -40 |
| Capital expenditure | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | -0.1 | -0.2 |
| Free cash flow | -37 | -36 | -38 | -33 | -41 | -31 | -39 | -40 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +130.1%, weakest 2023 at +2.5%. 3 of 3 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$0.14 |
| 5 Aug 2026 | −$0.52 |
| 7 May 2026 | −$0.40 |
| 18 Feb 2026 | −$0.63 |
| 5 Nov 2025 | −$0.61 |
| 6 Aug 2025 | −$0.15 |
| 8 May 2025 | −$0.34 |
| 26 Feb 2025 | −$0.95 |
| 6 Nov 2024 | −$0.18 |
| 7 Aug 2024 | −$0.41 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.0bn
- Market cap in trading currency
- $2.21bn
- Enterprise value
- $1.58bn
- P/E
- –
- P/S
- 85.13
- P/B
- 3.50
- EV/Sales
- 60.90
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -6.8%
Results (last four quarters)
- Revenue
- $25.9m
- Gross profit
- –
- EBITDA
- −$233m
- Net income
- −$205m
- Earnings per share
- −$1.69
- Revenue per share
- $0.22
- Revenue growth
- +5,406.9%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -900.1%
- Net margin
- -789.9%
- Return on equity
- -30.2%
- Return on assets
- -29.8%
Balance sheet and cash flow
- Cash
- $628m
- Cash per share
- $5.24
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 11.76
- Book value per share
- $5.26
- Operating cash flow
- −$150m
- Free cash flow
- −$151m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 120m
- Volume
- 1.74m
- Avg. volume 3 months
- 1.61m
- Relative volume
- 1.0
Price and technicals
- Price
- $18.41
- 1 day
- −5.6%
- 52-week high
- $41.45
- 52-week low
- $18.41
- Distance to 52-week high
- −55.6%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −12.7%
- Distance to 200-day line
- −36.2%
- RSI (14)
- 38
- Volatility 1M
- 69.3%
Performance
- 1 week
- −8.6%
- 1 month
- −14.7%
- 3 months
- −31.4%
- 6 months
- −48.1%
- YTD
- −47.5%
- 1 year
- −52.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has NAMS performed since 11/2022?
$10,000 grew to $17,787 by 20 Nov 2026, which is +15.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is NAMS?
Volatility was 61.7% per year, measured on monthly returns. The largest decline from a peak was −66.2%, with the low in 10/2023.
How does NAMS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.5% per year at 13.2% volatility, NAMS returned +15.5% at 61.7%. The correlation of monthly returns was 0.07; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.